Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reducing symptom limitations: a cognitive behavioral intervention randomized trial.

Ardith Doorenbos1, Barbara Given, Charles Given

  • 1College of Nursing, Michigan State University, East Lansing, MI 48824, USA. Ardith.doorenbos@hc.msu.edu

Psycho-Oncology
|January 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CYP gene variants show preliminary evidence of association with patient-reported outcomes in active-duty service members with chronic pain.

Molecular pain·2026
Same author

Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39).

JCO oncology practice·2026
Same author

Patient Engagement in the Design and Conduct of the HOPE Trial: Addressing Chronic Pain in Hemodialysis Patients.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Family functioning among adolescents with developmental disabilities utilizing augmentative and alternative communication.

Disability and rehabilitation. Assistive technology·2025
Same author

Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial.

Nature medicine·2025
Same author

Applying the Multiphase Optimization Strategy for the Development of a Culturally Tailored Resilience-Building Intervention to Facilitate Advance Care Planning Discussions for Chinese Americans: Protocol for a Survey and Qualitative Study.

JMIR research protocols·2024

Cognitive behavioral intervention significantly reduced symptom limitations in newly diagnosed cancer patients undergoing chemotherapy. This approach proved effective in managing the impact of cancer and treatment on daily life.

Area of Science:

  • Oncology
  • Psychology
  • Nursing

Background:

  • Limited research exists on the reactive dimension of symptoms, specifically how they limit an individual's life.
  • Symptom limitations significantly impact the quality of life for cancer patients undergoing chemotherapy.
  • Problem-solving therapy offers a potential framework for interventions to mitigate symptom limitations.

Purpose of the Study:

  • To evaluate if a cognitive behavioral intervention (CBI) reduces symptom limitations in newly diagnosed cancer patients receiving chemotherapy.
  • To analyze changes in symptom limitations over time, adjusting for covariates.
  • To identify the most limiting cancer- and chemotherapy-related symptoms.

Main Methods:

  • A randomized control trial involving 237 newly diagnosed solid tumor cancer patients (aged 31-87).

Related Experiment Videos

  • The experimental group received an 18-week CBI (10 contacts) focused on cancer/chemotherapy symptoms.
  • The control group received conventional care, with interviews at baseline, 10, 20, and 32 weeks. Data analyzed using a two-level hierarchical linear model.

    • Main Results:

    • Participants receiving CBI reported significantly lower symptom limitation scores compared to the control group.
    • Initially, younger patients experienced more limitations, but this trend reversed by study's end.
    • The CBI was the primary factor in reducing symptom limitations.

    Conclusions:

    • Cognitive behavioral intervention is effective in decreasing symptom limitations for cancer patients on chemotherapy.
    • Nursing interventions may be particularly beneficial for younger patients managing cancer-related symptom limitations.
    • Further research should explore symptom management strategies tailored to different patient demographics.